Despite the widespread availability of a safe and effective vaccine, tetanus continues to be a significant public health problem in the developing countries.
Get full access to this article
View all access options for this article.
References
1.
OgunrinOAUnuigbeEI. Tetanus: an analysis of the prognosticating factors of cases seen in a tertiary hospital in a developing African country between 1990 and 2000. Trop Doct2004;34:240–1
2.
GeorgeAOOgunbiyiAOAmanor-BoaduSOluwolwOAKumuyiO. Tetanus in Nigeria: the economic burden. Trop Doct2005;35:126–7
3.
OjiniFIDanesiMA. Mortality of tetanus at the Lagos University Teaching Hospital, Nigeria. Trop Doct2005;35:178–81
4.
NidaH. Neonatal tetanus in Awassa: retrospective analysis of patients admitted over 5 years. Ethiop Med J2001;39:241–6
5.
Barros Miranda-FilhoDArraes de Alencar XinenesAAlci BaroneALuiz VazVGomes VieiraAGoncalves AlbulquerqueV. Randomised controlled trial of tetanus treatment with antitetanus immunoglobulin by intrathecal or intramuscular route. BMJ2004;328:615–7
